Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | KIT | P10721 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19655199 | 0.91 | MEN1 (0.35) | MEN1KMT2AMAPTPTGER1CSF1R | |
| SCHEMBL19655235 | 0.87 | MAPT (0.35) | MEN1KMT2AMAPTPTGER1CSF1R | |
| SCHEMBL23203963 | 0.86 | KDM4E (0.37) | MEN1KMT2APRKDCKDM4EATM | |
| SCHEMBL19655248 | 0.86 | L3MBTL1 (0.42) | MEN1KMT2AMAPTKDM4EATM | |
| SCHEMBL17809143 | 0.85 | MAPT (0.36) | MEN1KMT2AMAPTKDM4EATM | |
| SCHEMBL26413259 | 0.85 | KDM4E (0.36) | MEN1KMT2APRKDCKDM4EATM | |
| SCHEMBL19655246 | 0.84 | L3MBTL1 (0.41) | MEN1KMT2AMAPTKDM4EATM | |
| SCHEMBL17809148 | 0.84 | MAPT (0.35) | MEN1KMT2AMAPTPRKDCKDM4E | |
| SCHEMBL17809140 | 0.84 | KDM4E (0.32) | MEN1KMT2AMAPTCSF1RPDGFRB | |
| SCHEMBL17809142 | 0.84 | MAPT (0.34) | MEN1KMT2AMAPTKDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10840458-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-11-17 | — | — | US | disclosed |
| US-20170346022-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-11-30 | — | — | US | disclosed |
| US-20170346022-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170346022-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PDXK, MT-ND4L, PNPO | MEN1 2827/4885KMT2A 3170/4885MAPT 2438/4885 |
| US-10840458-B2 | Organic electroluminescent materials and devices | PDXK, MT-ND4L, PNPO | MEN1 2827/4885KMT2A 3170/4885MAPT 2438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.